Biomedical Engineering Reference
In-Depth Information
B
ONIFATI
MD, R
UZZA
G, B
ONOMETTO
P, B
ERARDINELLI
A, G
ORNI
K, O
RCESI
S, L
ANZI
G, and A
NGELINI
C (2000).
A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular
dystrophy. Muscle Nerve 23(9): 1344-1347.
B
ONUCCELLI
G, S
OTGIA
F, C
APOZZA
F, G
AZZERRO
E, M
INETTI
C, and L
ISANTI
MP (2007). Localized treatment
with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-
associated proteins in mdx mice. Cell Cycle 6(10): 1242-1248.
B
ONUCCELLI
G, S
OTGIA
F, S
CHUBERT
W, P
ARK
DS, F
RANK
PG, W
OODMAN
SE, I
NSABATO
L, C
AMMER
M, M
INETTI
C, and L
ISANTI
MP (2003). Proteasome inhibitor (MG-132) treatment of mdxmice rescues the expression
and membrane localization of dystrophin and dystrophin-associated proteins. Am J Pathol 163(4):
1663-1675.
B
ULFIELD
G, S
ILLER
WG, W
IGHT
PA, and M
OORE
KJ (1984). X chromosome-linked muscular dystrophy
(mdx) in the mouse. Proc Natl Acad Sci USA 81(4): 1189-1192.
C
AMPBELL
C and J
ACOB
P (2003). Deflazacort for the treatment of Duchenne dystrophy: a systematic review.
BMC Neurol 3: 7.
C
OLLINS
CA and M
ORGAN
JE (2003). Duchenne's muscular dystrophy: animal models used to investigate
pathogenesis and develop therapeutic strategies. Int J Exp Pathol 84(4): 165-172.
C
OOPER
BJ, V
ALENTINE
BA, W
ILSON
S, P
ATTERSON
DF, and C
ONCANNON
PW (1988). Canine muscular
dystrophy: confirmation of X-linked inheritance. J Hered 79(6): 405-408.
C
OSSU
G and S
AMPAOLESI
M (2007). New therapies for Duchenne muscular dystrophy: challenges, prospects
and clinical trials. Trends Mol Med 13(12): 520-526.
C
OTE
PD, M
OUKHLES
H, L
INDENBAUM
M, and C
ARBONETTO
S (1999). Chimaeric mice deficient in
dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet
23(3): 338-342.
D
ECONINCK
N, T
INSLEY
J,
DE
B
ACKER
F, F
ISHER
R, K
AHN
D, P
HELPS
S, D
AVIES
K, and G
ILLIS
JM (1997).
Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient
muscles of mice. Nat Med 3(11): 1216-1221.
D
ELLAVALLE
A, S
AMPAOLESI
M, T
ONLORENZI
R, T
AGLIAFICO
E, S
ACCHETTI
B, P
ERANI
L, I
NNOCENZI
A, G
ALVEZ
BG, M
ESSINA
G, M
OROSETTI
R, L
I
S, B
ELICCHI
M, P
ERETTI
G, C
HAMBERLAIN
JS, W
RIGHT
WE, T
ORRENTE
Y,
F
ERRARI
S, B
IANCO
P, and C
OSSU
G (2007). Pericytes of human skeletal muscle are myogenic precursors
distinct from satellite cells. Nat Cell Biol 9(3): 255-267.
DE
L
UCA
A, P
IERNO
S, L
IANTONIO
A, and C
ONTE
C
AMERINO
D (2002). Pre-clinical trials in Duchenne
dystrophy: what animal models can tell us about potential drug effectiveness. Neuromuscul Disord 12
(Suppl 1): S142-S146.
D
EZAWA
M, I
SHIKAWA
H, I
TOKAZU
Y, Y
OSHIHARA
T, H
OSHINO
M, T
AKEDA
S, I
DE
C, and N
ABESHIMA
Y (2005).
Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309(5732):
314-317.
D
ISATNIK
MH, D
HAWAN
J, Y
U
Y, B
EAL
MF, W
HIRL
MM, F
RANCO
AA, and R
ANDO
TA (1998). Evidence of
oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci 161(1): 77-84.
D
ODD
A, C
HAMBERS
SP, and L
OVE
DR (2004). Short interfering RNA-mediated gene targeting in the
zebrafish. FEBS Lett 561(1-3): 89-93.
D
ORCHIES
OM, W
AGNER
S, V
UADENS
O, W
ALDHAUSER
K, B
UETLER
TM, K
UCERA
P, and R
UEGG
UT
(2006). Green tea extract and its major polyphenol ()-epigallocatechin gallate improve muscle
function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol 290(2):
C616-C625.
E
MRAN
F, R
IHEL
J, A
DOLPH
AR, W
ONG
KY, K
RAVES
S, and D
OWLING
JE (2007). OFF ganglion cells cannot
drive the optokinetic reflex in zebrafish. Proc Natl Acad Sci USA 104(48): 19126-19131.
G
ASCHEN
F and B
URGUNDER
JM (2001). Changes of skeletal muscle in young dystrophin-deficient cats: a
morphological and morphometric study. Acta Neuropathol 101(6): 591-600.
G
AUD
A, S
IMON
JM, W
ITZEL
T, C
ARRE
-P
IERRAT
M, W
ERMUTH
CG, and S
EGALAT
L (2004). Prednisone reduces
muscle degeneration in dystrophin-deficient
Caenorhabditis elegans
. Neuromuscul Disord 14(6):
365-370.
G
IBSON
AJ, K
ARASINSKI
J, R
ELVAS
J, M
OSS
J, S
HERRATT
TG, S
TRONG
PN, and W
ATT
DJ (1995). Dermal
fibroblasts convert to a myogenic lineage in mdx mouse muscle. J Cell Sci 108(Pt 1): 207-214.
Search WWH ::
Custom Search